Search Results - "Lupo, Sydney"

Galectin-3 as a Prognostic Biomarker of Left Ventricular Assist Device Implantation Outcomes by Hoang, Ryan, Acosta, Mary E, Belkin, Mark N, Rasheed, Nabeel F, Siddiqi, Umar, Cruz, Jennifer M, Lupo, Sydney E, Stonebraker, Corinne R, Kalantari, Sara, Grinstein, Jonathan

“…We assessed the prognostic potential of Galectin-3 in a sample of 159 heart failure patients who received a left ventricular assist device (LVAD) implant from…”
Get full text

Figure of eight suture technique in aortic valve replacement decreases prosthesis-patient mismatch by Rasheed, Nabeel F, Stonebraker, Corinne, Li, Zhaozhi, Siddiqi, Umar, Lee, Andy C H, Li, Willa, Lupo, Sydney, Cruz, Jennifer, Cohen, William G, Staub, Cathy, Rodgers, Daniel, Myren, Mark, Combs, Pamela, Jeevanandam, Valluvan, Hibino, Narutoshi

“…While the pledget suture technique has been the standard for surgical aortic. valve replacement (AVR), discussion continues regarding the possibility of the…”
Get full text

SHP-1 Protein Tyrosine Phosphatase Affects Early Postnatal Bone Development in Mice by Markovics, Adrienn, Lupo, Sydney, Patel, Niyati, Mikecz, Katalin, Sumner, D. Rick, Ross, Ryan D.

“…The Src homology region 2 domain-containing phosphatase-1 (SHP-1) is an intracellular tyrosine phosphatase that plays a negative regulatory role in immune cell…”
Get full text

Quality of Anticoagulation With Phenprocoumon and Warfarin in Left Ventricular Assist Device Patients: A Multicenter Study by Schlöglhofer, Thomas, Marschütz, Angelika, Combs, Pamela, Stonebraker, Corinne, Lupo, Sydney, Jeevanandam, Valluvan, Riebandt, Julia, Schima, Heinrich, Zimpfer, Daniel, Meehan, Karen

Get full text

Quality of Anticoagulation With Phenprocoumon and Warfarin in Left Ventricular Assist Device Patients: A Multicenter Study by Schlöglhofer, Thomas, Marschütz, Angelika, Combs, Pamela, Stonebraker, Corinne, Lupo, Sydney, Jeevanandam, Valluvan, Riebandt, Julia, Schima, Heinrich, Zimpfer, Daniel, Meehan, Karen

“…of key results. INR, international normalized ratio; TTR, time in therapeutic range; PTR, percentage of tests in range; HRAE, hemocompatibility-related adverse…”
Get full text

A model for continued LVAD patient success: A 4‐year readmission‐free HeartMate 3 postoperative course by Stonebraker, Corinne, Lee, Andy, Siddiqi, Umar, Lupo, Sydney, Brownlee, Andrew R., Yang, Benjamin, Combs, Pamela, Jeevanandam, Valluvan

“…Unplanned readmissions frequently occur following the implantation of a durable left ventricular assist device (LVAD) due to complications such as…”
Get full text

1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI by Valgimigli, Marco, Spirito, Alessandro, Sartori, Samantha, Angiolillo, Dominick J., Vranckx, Pascal, de la Torre Hernandez, Jose M., Krucoff, Mitchell W., Bangalore, Sripal, Bhatt, Deepak L., Campo, Gianluca, Cao, Davide, Chehab, Bassem M., Choi, James W., Feng, Yihan, Ge, Junbo, Hermiller, James, Kunadian, Vijay, Lupo, Sydney, Makkar, Raj R., Maksoud, Aziz, Neumann, Franz-Josef, Picon, Hector, Saito, Shigeru, Sardella, Gennaro, Thiele, Holger, Toelg, Ralph, Varenne, Olivier, Vogel, Birgit, Zhou, Yujie, Windecker, Stephan, Mehran, Roxana

“…The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients on long-term oral anticoagulation (OAC)…”
Get full text

B-6 | Prognostic Impact of Procedural Complexity in Octogenarians Undergoing Percutaneous Coronary Intervention by Gao, Michael, Spirito, Alessandro, Sartori, Samantha, Lupo, Sydney, Pileggi, Brunna, Smith, Kenneth, Jiang, Yijia, Nicosia, Danielle, Vogel, Birgit, Sweeny, Joseph, Sharma, Samin K., Kini, Annapoorna S., Dangas, George D., Mehran, Roxana

Get full text

A-28 | Prognostic Impact of Blood Glucose Level in Patients Undergoing PCI by Johnson, James Wheeler, Spirito, Alessandro, Sartori, Samantha, Kamaleldin, Karim M., Lupo, Sydney, Feng, Yihan, Jiao, Xiaoluo, Vogel, Birgit, Sweeny, Joseph, Sharma, Samin K., Kini, Annapoorna S., Dangas, George D., Mehran, Roxana

Get full text

A model for continued LVAD patient success: A 4-year readmission-free HeartMate 3 postoperative course by Stonebraker, Corinne, Lee, Andy, Siddiqi, Umar, Lupo, Sydney, Brownlee, Andrew R, Yang, Benjamin, Combs, Pamela, Jeevanandam, Valluvan

Get full text